Harvard Bioscience, Inc. ( HBIO) - Key Metrics
HBIO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $5.02 | -$0.64 | $0.07 | -$0.08 |
| 2026Q1 | $4.64 | -$0.77 | -$0.15 | -$0.24 |
| 2025Q4 | $5.35 | -$0.64 | -$0.02 | -$0.16 |
| 2025Q3 | $4.62 | -$0.28 | $0.24 | $0.17 |
| 2025Q2 | $4.62 | -$0.52 | $0.62 | $0.57 |
HBIO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.40 |
| 2026Q1 | 0% | -1.58 |
| 2025Q4 | 0% | -2.61 |
| 2025Q3 | 0% | -3.98 |
| 2025Q2 | 0% | -2.16 |
HBIO
Price: $8.09
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.23 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 13674
Ebitda: 836000Market Capitalization: 38.6 million